AstraZeneca price target raised to $97 from $93 at Berenberg
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
40 minutes ago
- Business Insider
Sabra Healthcare REIT (SBRA) Receives a Buy from Bank of America Securities
In a report released on July 8, Jeffrey Spector from Bank of America Securities reiterated a Buy rating on Sabra Healthcare REIT, with a price target of $20.00. The company's shares closed yesterday at $18.46. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Spector covers the Real Estate sector, focusing on stocks such as Agree Realty, Cousins Properties, and Welltower. According to TipRanks, Spector has an average return of 3.2% and a 46.63% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $19.67 average price target. The company has a one-year high of $20.03 and a one-year low of $15.60. Currently, Sabra Healthcare REIT has an average volume of 2.55M. Based on the recent corporate insider activity of 68 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SBRA in relation to earlier this year. Most recently, in May 2025, Michael J Foster, a Director at SBRA sold 11,000.00 shares for a total of $200,310.00.
Business Insider
40 minutes ago
- Business Insider
New Found Gold (NFGC) Receives a Buy from Roth MKM
In a report released on July 8, Mike Niehuser from Roth MKM maintained a Buy rating on New Found Gold, with a price target of $5.00. The company's shares closed yesterday at $1.54. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Niehuser covers the Basic Materials sector, focusing on stocks such as Perpetua Resources, Idaho Strategic Resources, and Solitario Exploration & Royalty. According to TipRanks, Niehuser has an average return of 13.8% and a 54.43% success rate on recommended stocks. New Found Gold has an analyst consensus of Hold. Based on New Found Gold's latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $8.94 million. In comparison, last year the company had a GAAP net loss of $13.18 million Based on the recent corporate insider activity of 13 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of NFGC in relation to earlier this year.
Business Insider
40 minutes ago
- Business Insider
Lowe's (LOW) Receives a Buy from Bernstein
Bernstein analyst Zhihan Ma maintained a Buy rating on Lowe's on July 8 and set a price target of $266.00. The company's shares closed yesterday at $224.13. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Ma covers the Consumer Cyclical sector, focusing on stocks such as Costco, Dollar General, and Lowe's. According to TipRanks, Ma has an average return of 6.4% and a 55.26% success rate on recommended stocks. Currently, the analyst consensus on Lowe's is a Moderate Buy with an average price target of $263.13. The company has a one-year high of $287.01 and a one-year low of $206.39. Currently, Lowe's has an average volume of 2.63M. Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of LOW in relation to earlier this year. Last month, JULIETTE WILLIAMS PRYOR, the EVP, CLO & Corp. Sec of LOW sold 1,130.00 shares for a total of $257,075.00.
